We are live on ! Find out more
IRTC icon

iRhythm Holdings

114.72 USD
+3.29
2.95%
At close Updated Sep 14, 4:00 PM EDT
Pre-market
After hours
114.72
0.00
0%
1 day
2.95%
5 days
-5.49%
1 month
-9.27%
3 months
0.84%
6 months
0.84%
Year to date
-34.53%
1 year
-34.88%
5 years
87.08%
10 years
340.38%
 

About: iRhythm Holdings Inc is a digital healthcare company that creates trusted solutions that detect, predict, and prevent disease. Its principal business is the design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services that it believes allow clinicians to diagnose certain arrhythmias quicker and with greater efficiency than other services that rely on traditional technology. Each Zio System combines an FDA-cleared and CE-marked, wire-free, patch-based, 14-day wearable biosensor that continuously records electrocardiogram (ECG) data with a proprietary, FDA-cleared, CE-marked cloud-based data analytic software to help physicians monitor patients and diagnose arrhythmias.

Employees: 2,400

News

Positive
Neutral
Negative
Sentiment 3-Months
Positive 38.1%
Neutral 61.9%
Negative 0%
Positive
Zacks Investment Research
10 days ago
Should Investors Buy IRTC as Growth Improves but Risks Stay Elevated?
iRhythm's Q2 revenue growth, margin expansion and record free cash flow strengthen its case, but reimbursement and regulatory risks remain elevated.
Should Investors Buy IRTC as Growth Improves but Risks Stay Elevated?
Neutral
GlobeNewsWire
19 days ago
iRhythm Holdings to Participate in Wells Fargo 21st Annual Healthcare Conference
SAN FRANCISCO, Aug. 26, 2026 (GLOBE NEWSWIRE) -- iRhythm Holdings, Inc. (NASDAQ: IRTC), a leading digital health care company focused on creating trusted solutions that detect, predict, and prevent disease, today announced that it will participate in the upcoming Wells Fargo 21st Annual Healthcare Conference.
iRhythm Holdings to Participate in Wells Fargo 21st Annual Healthcare Conference
Positive
Seeking Alpha
24 days ago
iRhythm: The Algorithmic Margin Inflection Changes The Story
iRhythm Technologies is evolving from a cardiac patch producer to a comprehensive cardiac monitoring platform, leveraging software and workflow integration for a competitive advantage. Q2 2026 marked a financial inflection: 20.1% revenue growth, 72.8% gross margin, and adjusted EBITDA margin expansion to 19.3%, with raised full-year guidance and record free cash flow. The ZEUS platform's FDA clearance enables significant margin leverage, reducing clinician review time by 50% and targeting $100 million in cost savings over five years.
iRhythm: The Algorithmic Margin Inflection Changes The Story
Neutral
PRNewsWire
28 days ago
Did iRhythm Technologies, Inc. Insiders Breach their Fiduciary Duties to Shareholders?
Shareholders are encouraged to contact the firm to discuss their rights and options at no cost or obligation. We would handle any matter on a contingent fee basis, whereby you would not be responsible for out-of-pocket payment of our legal fees or expenses.
Did iRhythm Technologies, Inc. Insiders Breach their Fiduciary Duties to Shareholders?
Positive
Zacks Investment Research
1 month ago
iRhythm to Acquire VitalConnect to Expand Cardiac Monitoring Platform
IRTC's VitalConnect deal expands its cardiac monitoring reach across ambulatory, inpatient and hospital-to-home care while opening new growth opportunities.
iRhythm to Acquire VitalConnect to Expand Cardiac Monitoring Platform
Positive
Zacks Investment Research
1 month ago
Here's Why iRhythm Holdings, Inc. (IRTC) is a Strong Momentum Stock
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Here's Why iRhythm Holdings, Inc. (IRTC) is a Strong Momentum Stock
Positive
Zacks Investment Research
1 month ago
iRhythm Q2 Earnings Beat Estimates on Volume Growth, '26 View Raised
IRTC posts 20.1% revenue growth, margin expansion and a higher 2026 outlook while advancing innovation and its Vital Connect acquisition.
iRhythm Q2 Earnings Beat Estimates on Volume Growth, '26 View Raised
Neutral
PRNewsWire
1 month ago
Kuehn Law Encourages Investors of iRhythm Technologies, Inc. to Contact Law Firm
NEW YORK, Aug. 8, 2026 /PRNewswire/ -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of iRhythm Technologies, Inc. (NASDAQ: IRTC)  breached their fiduciary duties to shareholders.  According to a federal securities lawsuit, Insiders at iRhythm caused the company to misrepresent or fail to disclose that the Zio AT monitor was a real-time monitor intended for high-risk patients.
Kuehn Law Encourages Investors of iRhythm Technologies, Inc. to Contact Law Firm
Positive
Benzinga
1 month ago
iRhythm Combines Strong Performance with VitalConnect Buy to Expand Remote Cardiac Care
Digital healthcare company iRhythm Holdings, Inc. (NASDAQ:IRTC) on Thursday agreed to acquire Vital Connect, Inc., a privately held developer of wearable biosensor technology.
iRhythm Combines Strong Performance with VitalConnect Buy to Expand Remote Cardiac Care
Neutral
Seeking Alpha
1 month ago
iRhythm Holdings, Inc. (IRTC) Q2 2026 Earnings Call Transcript
iRhythm Holdings, Inc. (IRTC) Q2 2026 Earnings Call Transcript
iRhythm Holdings, Inc. (IRTC) Q2 2026 Earnings Call Transcript
Price charts implemented using Lightweight Charts™